|
Title
|
|
|
|
Conducting radiogenomic research : do not forget careful consideration of the clinical data
|
|
|
Author
|
|
|
|
|
|
|
Institution/Organisation
|
|
|
|
ESTRO GENEPI Network
|
|
|
Abstract
|
|
|
|
| The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 337-340 |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Radiotherapy and oncology. - Amsterdam
|
|
|
Publication
|
|
|
|
Clare
:
Elsevier ireland ltd
,
2012
|
|
|
ISSN
|
|
|
|
0167-8140
|
|
|
DOI
|
|
|
|
10.1016/J.RADONC.2012.11.004
|
|
|
Volume/pages
|
|
|
|
105
:3
(2012)
, p. 337-340
|
|
|
ISI
|
|
|
|
000313608300010
|
|
|
Pubmed ID
|
|
|
|
23245646
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|